Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Enterprise AI Budgets to Swell Tenfold, Alibaba Cloud Exec Says
Moonshot AI Rules Out Quick IPO After Raising $500 Million
Memory Chipmaker ChangXin Seeks $4.2 Billion in IPO Amid AI Boom
LATEST
MiniMax Kicks Off $540 Million Hong Kong IPO Amid AI Gold Rush
Memory Chipmaker ChangXin Seeks $4.2 Billion in IPO Amid AI Boom
Moonshot AI Rules Out Quick IPO After Raising $500 Million
Enterprise AI Budgets to Swell Tenfold, Alibaba Cloud Exec Says
Smart-Home Startup OneRobotics Lands $206 Million in HK IPO, Bets Big on AI Bots
Chinese GPU-Maker Iluvatar CoreX Seeks $475 Million in Hong Kong Listing
Zhipu AI Seeks Up to $640 Million in Hong Kong IPO
Meta Acquires Chinese-Founded AI Agent Startup Manus
Xiaomi Co-Founder Plans $2 Billion Share Sale to Back New Fund
China Proposes Rules on AI Companion Apps to Curb Addiction
Cover Story: China’s AI Titans Escalate Battle for Control of Digital Gateways
Robot-Maker UBTech Tries for A-Share Foothold With Takeover of Auto Parts Firm
U.S. to Hit Chinese Chips With New Tariffs in 2027
Deep Robotics Starts IPO Tutoring for Mainland Listing
China’s Semiconductor M&A Spree Hits Snag on Valuation Clashes
Cash-Hungry China AI Companies Turn to Hong Kong Listings
Chinese GPU-Maker Moore Threads Unveils AI Chip to Rival Nvidia
China Unveils Draft Rules to Speed Certification of eVTOL Aircraft
China’s AI Talent Supply Outpaces Demand, Survey Shows
Surge in Model Token Use to Send China’s AI Market Value Soaring, Industry Expert Says

By Charlotte Yang / Dec 11, 2018 07:10 PM / Economy

Photo: VCG

Photo: VCG

Changsheng Bio-Technology, which in a high-profile scandal earlier this year was revealed to have fabricated data on its vaccines for infants, has received an advance notification of mandatory delisting from the Shenzhen Stock Exchange.

The exchange described the vaccine-maker's illegal activities as “seriously damaging to national interests and public interests.”

In a separate announcement, the company said the China Securities Regulatory Commission fined 17 related personnel for market violations, banned four from entering China’s stock markets for life, and three from entering the market for five years.

Related: Data-Faking Vaccine Firm to Be Kicked Off Stock Exchange Under New Rules


Share this article
Open WeChat and scan the QR code